Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Liraglutide is recommended at a starting dose of 0.6 mg daily for the first week, followed by an upward titration to 1.2 mg daily
However, rates of these side effects are lower compared with other more common ones, like nausea, vomiting, and diarrhea
Whenever you see any claim about a peptide being linked to a higher risk of cancer, ask yourself if what youre reading is a theoretical risk or a proven outcome
However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects
